Therapeutic suppression of specific immune responses by administ

Drug – bio-affecting and body treating compositions – Lymphokine

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 89, 424 90, 424 91, 424 92, 514 2, 514 8, 514 10, 514 21, 530403, 530402, 530404, 530405, 530406, 530807, 530810, 530813, A61K 39395

Patent

active

051261316

ABSTRACT:
Undesired immune responses are suppressed by administering a nonimmunogenic material which comprises one or more haptens or epitopes corresponding to the antigen which causes the undesired immune response, the number and spacing of the haptens or epitopes being insufficient to trigger an immune response but sufficient to inhibit it. Also disclosed is an improved vaccine from which low molecular weight suppressive polymer has been removed.

REFERENCES:
patent: 3794630 (1974-02-01), Mullan
patent: 3869546 (1975-03-01), Lund
patent: 3919411 (1975-11-01), Glass
patent: 4140679 (1979-02-01), Malley
patent: 4191668 (1980-03-01), Katz
patent: 4253995 (1981-03-01), Katz
patent: 4261973 (1981-04-01), Lee
patent: 4310514 (1982-01-01), Durette
Desaynard, C. et al, Eur. J. Immunol, vol. 5, pp. 541-545 (1975).
Lui, F. et al, Proc. Natl. Acad. Sci, U.S.A., vol. 76(3), pp. 1430-1434 (1979).
Peacock, J. S. et al., J. Immunology, vol. 127(3) pp. 900-906 (1981).
Immunological Reviews, vol. 50, Unresponsivenes To Haptenated Self Structures, Copenhagen (1980).
Immunological Reviews, vol. 43, Mechanism of B Lymphocyte Tolerance, Copenhagen (1979).
Brown, H. M. et al., Acta Allergolagica, vol. 31, pp. 22-34 (1976).
Feldmann, M., J. Exper. Med, vol. 135, pp. 735-753 (1972).
Feldmann, M. et al. Extracellular Matrix Influence on Gene Expression, Academic Press, London (1975).
Perelson, A. A. et al. in Paradoxes in Immunology, Hoffman, G. W. et al. eds, CRC Press, Boca Raton, Fla. (1986), pp. 199-214.
Dintzis et al, "Molecular Determinants of Immunogenicity: The Immunon Model of Immune Response", Proc. Natl. Acad. Sci. U.S.A., vol. 73, No. 10, pp. 3671-3675, Oct. 1976.
"Specific Cellular Stimulation in the Primary Immune Response: A Quantized Model" by B. Vogelstein et al, Proc. Natl. Acad. Sci, U.S.A. vol. 79, pp. 395-399, Jan. 1982.
"Specific Cellular Stimulation in the Primary Immune Response: Experimental Test of a Quantized Model" by R. Z. Dintzis et al, Proc. Natl. Acad. Sci, U.S.A., vol. 79, pp. 884-888, Feb. 1982.
"Studies on the Immunogenicity and Tolerogenicity of T-Independent Antigens", by Renee Z. Dintzis et al, The Journal of Immunology, vol. 131, No. 5, Nov. 1983.
Chiorazzi et al, Proc. Natl. Acad. Sci. U.S.A., vol. 73, No. 6, pp. 2091-2095, Jun. 1976.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic suppression of specific immune responses by administ does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic suppression of specific immune responses by administ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic suppression of specific immune responses by administ will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1862467

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.